Valuation GSK plc

Equities

Real-time Estimate Cboe Europe Other stock markets 08:27:38 17/03/2026 pm IST			5-day change	1st Jan Change
2,017.50 ^GBX	-0.42%		-2.08%	+10.77%

06:39pm	Bicycle Therapeutics plc Announces Executive Changes, Effective March 12, 2026	CI
16/03	Tech vs. Turmoil

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	80,458	58,381	59,112	54,944	73,201	81,119	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	10.82%	-	-
Enterprise Value (EV) ¹	1,00,296	75,578	74,152	68,039	87,654	93,101	90,373	88,391
Change	-	-24.65%	-1.89%	-8.24%	28.83%	6.21%	-2.93%	-2.19%
P/E ratio	18.6x	3.93x	11.9x	21.3x	12.9x	12.7x	11.8x	11.3x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.32x	3.6x	3.2x
PEG	-	0x	-0.2x	-0.4x	0x	1x	1.52x	2.67x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.4x	2.29x	2.22x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.75x	2.55x	2.42x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.97x	7.28x	6.99x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.15x	8.2x	7.6x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	14.6x	14.1x	12.3x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.85%	7.1%	8.11%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.693	0.761	0.7633
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.42%	3.76%	3.77%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.594	1.717	1.79
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	43.5%	44.3%	42.6%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,804	35,419	36,517
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,681	12,415	12,648
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,174	11,021	11,627
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,311	6,796	7,183
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	11,982	9,253	7,272
Reference price ²	20.08	14.38	14.50	13.46	18.24	20.26	20.26	20.26
Nbr of stocks (in thousands)	40,06,383	40,60,999	40,76,145	40,80,519	40,12,126	40,03,922	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	12.71x	2.75x	7.97x	3.42%	11TCr
ELI LILLY AND COMPANY	29.07x	10.95x	22x	0.67%	88TCr
JOHNSON & JOHNSON	25.8x	6x	16.34x	2.18%	59TCr
ABBVIE INC.	24.19x	6.6x	13.25x	3.13%	39TCr
ROCHE HOLDING AG	17.41x	4.24x	10.49x	3.12%	33TCr
ASTRAZENECA PLC	24x	4.98x	13.88x	1.74%	30TCr
NOVARTIS AG	20.97x	5.65x	13.98x	2.86%	29TCr
MERCK & CO., INC.	26.98x	4.73x	14.8x	2.92%	29TCr
AMGEN INC.	24.64x	6.26x	11.14x	2.74%	20TCr
GILEAD SCIENCES, INC.	20.13x	6.12x	11.08x	2.24%	18TCr
Average	22.59x	5.83x	13.49x	2.5%	35.48TCr
Weighted average by Cap.	24.46x	6.84x	15.53x	2.15%